nepafenac: Clinical Trials

7 trials of nepafenac, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated, 1 unknown. 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 27Completed 5, Terminated 1, Unknown 1

Follow nepafenac: new trials by email Literature Review of nepafenac trials Research Report on nepafenac

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops
Nepafenac 0.1% Oph Susp, Refresh Tears 0.5% Lubricant Eye Drops - Congenital Hereditary Endothelial Dystrophy of Cornea
Phase 2UnknownL.V. Prasad Eye Institute302020-12-152021-04-14
Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification
PRO-155, Nevanac - Cataract, Phacoemulsification Cataract Surgery
Phase 2CompletedLaboratorios Sophia S.A de C.V.1602013-12-012018-10-30
NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)
nepafenac 0.1% drops, Nepafenac Vehicle - Diabetic Macular Edema
Phase 2CompletedJaeb Center for Health Research1252011-05-012025-03-10
Nepafenac 0.3% Two Study
Nepafenac Ophthalmic Suspension, 0.3%, Nepafenac Ophthalmic Suspension, 0.1%, Nepafenac Vehicle 0.3% - Cataract
Phase 2CompletedAlcon Research13422011-03-012012-12-17
A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
Nepafenac ophthalmic suspension, 0.1% (NEVANAC), Nepafenac ophthalmic suspension vehicle, Prednisolone acetate ophthalmic suspension (OMNIPRED) - Macular Edema
Phase 2CompletedAlcon Research2632008-11-012012-10-26
Effect of Topical Nepafenac in Macular Thickening Related to Pan-retinal Photocoagulation
Nepafenac, Lubricant - Macular Thickening, Macular Edema
Phase 2TerminatedAsociación para Evitar la Ceguera en México502008-08-012024-05-30
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
Ketorolac, Nepafenac, Polietilenglicol 400, propilenglicol - Diabetic Retinopathy, Macular Edema
Phase 2CompletedHospital Juarez de Mexico842008-04-012015-03-20

Conditions studied

Macular Edema (4)  ·  Cataract (2)  ·  Diabetic Retinopathy (2)  ·  Corneal Dystrophy, Posterior Polymorphous, 1 (1)  ·  Inflammation (1)  ·  Pain (1)

Sponsors

Alcon Research (2)  ·  Asociación para Evitar la Ceguera en México (1)  ·  Hospital Juarez de Mexico (1)  ·  Jaeb Center for Health Research (1)  ·  L.V. Prasad Eye Institute (1)  ·  Laboratorios Sophia S.A de C.V. (1)

Countries

Mexico (3)  ·  United States (2)  ·  India (1)

Top investigators

Dulce O Rascon-Vargas, Fellow (1)  ·  Guadalupe Cervantes-Coste (1)  ·  Jans Fromow-Guerra (1)  ·  Juan Asbun Bojalil, MD, PhD (1)  ·  Muralidhar Ramappa, MS (1)  ·  Neet Y Mehta, MBBS (1)  ·  Scott M Friedman, MD (1)  ·  Virgilio Lima Gomez, MD, MSc (1)

Results publications

PMID 22927737, PMID 25602634, PMID 27388251

NIH funding

U10EY014231 (1), U10EY018817 (1)